StocksEditas Medicine IncEDIT

EDIT

Editas Medicine Inc

35.77 1.43 (4.16%)
Delayed Prices By NASDAQ, in USD Market Closed
Trade
S
35.77
B
35.90

Editas Medicine Inc

Editas Medicine Inc. (formerly known as Gengine Inc.) was founded in 2013 and is based in Cambridge, Massachusetts. It is focused on the development of a genome-editing platform, targeting genetically defined diseases without an existing approved solution. The company’s process is based on a unique technology... Show More
Last Month
26,866
Followers
1.71%
Investors
100% Of them have BUY positions.
A decrease of -0.52% from last trading Day

Related Markets

Koninklijke Boskalis Westminster NV
BOKA.NV
0.16 (0.61%)
S
26.58
B
26.64
Arcadis NV
ARCAD.NV
0.11 (0.32%)
S
34.47
B
34.57
Groupe ADP
ADP.PA
-0.29 (-0.29%)
S
101.26
B
101.59
Boeing
BA
1.86 (0.79%)
S
235.69
B
236.15
Genuit Group PLC
GEN.L
2.00 (0.36%)
S
558.50
B
561.50
View More

Investors

View More
Pinned Post
Edited
Clement Victor Gonzalez
📉 WHY EDITAS MEDICINE SELLOFF LOOKS OVERDONE? 🔸 What Happened to the stock? The shares of Editas Medicine dropped more than 15% last Friday, after Goldman Sachs initiated coverage on $EDIT (Editas Medicine Inc) stock with a “Sell” rating and a $20 price target. At the time, the stock price was around... Show More
Like CommentShare
Show more comments2 of 3
1 reply
null
.